Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Borge G. Nordestgaard et al.
ATHEROSCLEROSIS (2020)
Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study
Frida Emanuelsson et al.
DIABETES CARE (2020)
Measuring LDL-cholesterol: what is the best way to do it?
Anna Wolska et al.
CURRENT OPINION IN CARDIOLOGY (2020)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
Qiuhong Gong et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease A Mendelian Randomization Study
Frida Emanuelsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Nonfasting versus fasting lipid profile for cardiovascular risk prediction
Anne Langsted et al.
PATHOLOGY (2019)
HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study
Matthew B. Lanktree et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study
Ning Ding et al.
ATHEROSCLEROSIS (2018)
The Vasculature in Prediabetes
David H. Wasserman et al.
CIRCULATION RESEARCH (2018)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
The metabolic-microvascular dysregulation syndrome
Coen D. A. Stehouwer
ARTERY RESEARCH (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread Consequences
Coen D. A. Stehouwer
DIABETES (2018)
Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease
Frida Emanuelsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Peripheral artery disease: epidemiology and global perspectives
F. Gerry R. Fowkes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
Sophia Zoungas et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
Pamela Piscitelli et al.
SCIENTIFIC REPORTS (2017)
Microvascular Function and Endothelial Progenitor Cells in Patients with Severe Hypercholesterolemia and the Familial Hypercholesterolemia Phenotype
Andrea De Lorenzo et al.
CARDIOLOGY (2017)
Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
Xiaole Su et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)
Leopoldo Perez de Isla et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
Manfredi Rizzo et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis
J. B. Echouffo-Tcheugui et al.
DIABETIC MEDICINE (2016)
Predictors of chronic kidney disease in type 2 diabetes A longitudinal study from the AMD Annals initiative
Salvatore De Cosmo et al.
MEDICINE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population
Brian C. Callaghan et al.
JAMA NEUROLOGY (2016)
Peripheral arterial disease in heterozygous familial hypercholesterolemia
Carolina Pereira et al.
ATHEROSCLEROSIS (2015)
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Joseph L. Goldstein et al.
CELL (2015)
The Genetic Basis of Peripheral Arterial Disease Current Knowledge, Challenges, and Future Directions
Iftikhar J. Kullo et al.
CIRCULATION RESEARCH (2015)
Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes
Christopher J. Nolan et al.
DIABETES (2015)
Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials
Partha Sardar et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
David M. Nathan
LANCET DIABETES & ENDOCRINOLOGY (2015)
Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
Anawin Sanguankeo et al.
PLOS ONE (2015)
Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology
Kristen Fedak et al.
EMERGING THEMES IN EPIDEMIOLOGY (2015)
Relation of Serum Lipids and Lipoproteins with Progression of CKD: The CRIC Study
Mahboob Rahman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: Observations from the Dallas Heart Study
Frank Y. F. Xing et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
John M. Lachin et al.
DIABETES CARE (2014)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Association between LDL-C and Risk of Myocardial Infarction in CKD
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories
Jeffrey S. Berger et al.
JOURNAL OF VASCULAR SURGERY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Disease Location Is Associated With Survival in Patients With Peripheral Arterial Disease
Qian Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men
Michel M. Joosten et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction A Mendelian Randomization Study
Marianne Benn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
Robert A. Scott et al.
NATURE GENETICS (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Susceptibility of LDL and its subfractions to glycation
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Association of a Fasting Glucose Genetic Risk Score With Subclinical Atherosclerosis The Atherosclerosis Risk in Communities (ARIC) Study
Laura J. Rasmussen-Torvik et al.
DIABETES (2011)
Glycemic Thresholds for Diabetes-Specific Retinopathy Implications for diagnostic criteria for diabetes
Stephen Colagiuri et al.
DIABETES CARE (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.
Elizabeth Selvin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
Emily Y. Chew et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Retinopathy in Nondiabetic Persons with the Metabolic Syndrome: Findings from the Third National Health and Nutrition Examination Survey
Jeremy D. Keenan et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease
Aaron R. Folsom et al.
ATHEROSCLEROSIS (2009)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
The Pathologic Continuum of Diabetic Vascular Disease
Gabriela Orasanu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Kausik K. Ray et al.
LANCET (2009)
Mechanotransduction in vascular physiology and atherogenesis
Cornelia Hahn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Neuropathic Pain in Diabetes, Prediabetes and Normal Glucose Tolerance: The MONICA/KORA Augsburg Surveys S2 and S3
Dan Ziegler et al.
PAIN MEDICINE (2009)
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Debbie A. Lawlor et al.
STATISTICS IN MEDICINE (2008)
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
A. C. Keech et al.
LANCET (2007)
Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells
Rosaria Piga et al.
ATHEROSCLEROSIS (2007)
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
JOURNAL OF VASCULAR SURGERY (2007)
Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?
Jenny E. Kanter et al.
CIRCULATION RESEARCH (2007)
Large and small vessels atherosclerosis: Similarities and differences
Victor Aboyans et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Dyslipidaemia and microvascular disease in the retina
H Leung et al.
EYE (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia
K Yagi et al.
CIRCULATION JOURNAL (2004)
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis
K Kornerup et al.
ATHEROSCLEROSIS (2003)
Initial management of glycemia in type 2 diabetes mellitus
DM Nathan
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The association of atherosclerosis, vascular risk factors, and retinopathy in adult's with diabetes - The atherosclerosis risk in communities study
R Klein et al.
OPHTHALMOLOGY (2002)
Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study
JM Murabito et al.
AMERICAN HEART JOURNAL (2002)
The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study
R Klein et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity
HL Hillege et al.
JOURNAL OF INTERNAL MEDICINE (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prevalence of and risk factors associated with carotid artery stenosis: The Tromso Study
EB Mathiesen et al.
CEREBROVASCULAR DISEASES (2001)
Share Paper
